A.J. Day, PharmD, PCCA Vice President of Clinical Services, joins Mike and Sebastian to discuss various details of federal oversight on 503A compounding as well as an important FDA ruling on several bulk substances related to compounding for human use, which goes into effect on March 21, 2019.